Acadia Healthcare (NASDAQ:ACHC) Downgraded to “Sell” at

Acadia Healthcare (NASDAQ:ACHCGet Free Report) was downgraded by from a “hold” rating to a “sell” rating in a research note issued on Friday.

ACHC has been the subject of several other research reports. UBS Group upped their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price objective for the company in a research report on Thursday, April 25th. Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 target price on the stock in a research note on Friday, January 5th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, March 5th. Finally, Mizuho cut their price objective on Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a report on Friday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. Based on data from, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Read Our Latest Report on ACHC

Acadia Healthcare Trading Down 0.9 %

ACHC stock traded down $0.61 during midday trading on Friday, reaching $66.12. 1,181,258 shares of the company traded hands, compared to its average volume of 604,466. The firm has a market capitalization of $6.11 billion, a price-to-earnings ratio of -472.29, a P/E/G ratio of 2.15 and a beta of 1.31. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The business has a 50 day moving average of $77.13 and a 200-day moving average of $77.61. Acadia Healthcare has a 52-week low of $64.74 and a 52-week high of $87.77.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last issued its quarterly earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.56%. The company had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. During the same period in the prior year, the firm posted $0.75 EPS. The firm’s revenue was up 9.1% compared to the same quarter last year. As a group, sell-side analysts expect that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors have recently made changes to their positions in the company. Headlands Technologies LLC bought a new position in Acadia Healthcare in the third quarter worth about $25,000. GAMMA Investing LLC acquired a new position in Acadia Healthcare during the 4th quarter valued at approximately $26,000. Mather Group LLC. bought a new position in Acadia Healthcare during the 1st quarter worth $48,000. Fifth Third Bancorp lifted its stake in Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare during the third quarter valued at $96,000.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Further Reading

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with's FREE daily email newsletter.